Unlock Advanced Pharmaceutical Synthesis with Our Key Intermediate
Essential for developing innovative treatments like Sparsentan for IgA Nephropathy.
Get a Quote & SampleProduct Core Value
![[1,1'-Biphenyl]-2-Sulfonamide, N-(4,5-Dimethyl-3-Isoxazolyl)-2'-(Ethoxymethyl)-4'-(Hydroxymethyl)-N-](https://www.nbinno.com/webimg/gemini_68818eb01f270_1753321136.png)
[1,1'-Biphenyl]-2-Sulfonamide, N-(4,5-Dimethyl-3-Isoxazolyl)-2'-(Ethoxymethyl)-4'-(Hydroxymethyl)-N-
This high-quality pharmaceutical intermediate is critical for the synthesis of Sparsentan, a novel therapeutic agent targeting IgA Nephropathy. Its rigorous production standards, including GMP and ISO 9001 certifications, ensure reliability and efficacy in advanced drug development.
- Leverage our CAS No. 1098924-76-5 intermediate for efficient Sparsentan intermediate synthesis, streamlining your research and production processes.
- As a vital chemical intermediate C23H28N2O6S, it plays a crucial role in the creation of pharmaceutical intermediates for IgA nephropathy therapies.
- Trust in the quality of this GMP certified pharmaceutical intermediate, sourced from reputable Nanjing Xinbell Pharmaceutical Technology.
- Utilize this compound as research chemical, ensuring precision in scientific research and analytical reagent applications.
Key Advantages
Synthesis Efficiency
Enhance your Sparsentan intermediate synthesis with a precisely manufactured compound, contributing to faster R&D cycles.
Therapeutic Relevance
Crucial for developing pharmaceutical intermediates for IgA nephropathy treatments, addressing significant unmet medical needs.
Quality Assurance
Benefit from a GMP certified pharmaceutical intermediate, ensuring compliance and product integrity in your pharmaceutical manufacturing.
Key Applications
Pharmaceutical Synthesis
This intermediate is essential for the targeted synthesis of active pharmaceutical ingredients, particularly in the development of novel kidney disease treatments.
IgA Nephropathy Treatment
Directly supports the production of Sparsentan, a leading drug candidate for IgA nephropathy, offering hope for patients with this progressive condition.
Drug Development Research
Serves as a vital research chemical for exploring new therapeutic avenues and optimizing drug efficacy in complex disease states.
Analytical Reagents
Its defined chemical structure and purity make it suitable for use as an analytical reagent in quality control and scientific studies.